A Naturalistic Study of Galantamine for Alzheimer's Disease

Author： Brodaty Henry  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.20, Iss.11, 2006-01, pp. : 935-943

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Naturalistic Treatment of Alzheimer's Disease with Galantamine: 12-Month Follow-Up from the NATURE Study

By Brodaty Henry  

CNS Drugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 335-336

Adis International

Access to resources Recommend Favorite

Galantamine for Alzheimer's disease

By Prvulovic David   Hampel Harald   Pantel Johannes  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite

Galantamine: A Review of its Use in Alzheimer's Disease

By Scott L.J.   Goa K.L.  

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 1095-1122

Adis International

Access to resources Recommend Favorite

Galantamine Extended Release in Alzheimer's Disease: Profile Report

By Robinson Dean M.   Plosker Greg L.  

Drugs & Aging, Vol. 23, Iss. 10, 2006-01 ,pp. : 839-842

Adis International

Access to resources Recommend Favorite

Galantamine: A Pharmacoeconomic Review of its Use in Alzheimer's Disease

By Lyseng-Williamson K.A.   Plosker G.L.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 919-942

Adis International

Access to resources Recommend Favorite